Diamantopoulos, P., Koumbi, D., Kotsianidis, I., Pappa, V., Symeonidis, A., Galanopoulos, A., Zikos, P., Papadaki, H. A., Panayiotidis, P., Dimou, M., Hatzimichael, E., Vassilopoulos, G., Delimpasis, S., Mparmparousi, D., Papageorgiou, S., Variami, E., Kyrtsonis, M., Megalakaki, A., Kotsopoulou, M., Repousis, P., Adamopoulos, I., Kontopidou, F., Christoulas, D., Kourakli, A., Tsokanas, D., Konstantinos Papoutselis, M., Kyriakakis, G., Viniou, N., & , (n.d.). the prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry. Cancer medicine, 8, 2056–2063. http://access.bl.uk/ark:/81055/vdc_100084066133.0x000012